Redcare Pharmacy NV (ETR:RDC)
Germany · Delayed Price · Currency is EUR 70.55
-1.95 (-2.69%)
Nov 6, 2026, 5:35 PM CET
Redcare Pharmacy NV Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 89.6 | 92.4 | 96.9 | 84.16 | 66.78 | 247.41 |
Short-Term Investments | 42.8 | 111.1 | 80.7 | 120 | 113.32 | 36.42 |
Cash & Short-Term Investments | 132.4 | 203.5 | 177.6 | 204.16 | 180.1 | 283.83 |
Cash Growth | -51.20% | 14.58% | -13.01% | 13.36% | -36.55% | 121.30% |
Accounts Receivable | 141.8 | 129.5 | 109.8 | 103.13 | 30 | 27.92 |
Other Receivables | - | 23.3 | 15 | 16.17 | 10.94 | 8.25 |
Receivables | 141.8 | 152.8 | 124.8 | 119.31 | 40.95 | 36.16 |
Inventory | 206.5 | 214 | 153.8 | 135.79 | 99.71 | 96.62 |
Prepaid Expenses | 67.2 | 16.6 | 18 | 10.89 | 6.57 | 3.7 |
Other Current Assets | - | 32.5 | 25.8 | 29.38 | 16.59 | 12.45 |
Total Current Assets | 547.9 | 619.4 | 500 | 499.52 | 343.92 | 432.76 |
Property, Plant & Equipment | 204.7 | 190.7 | 82.6 | 86.91 | 85.44 | 78.26 |
Long-Term Investments | 1.5 | 1.5 | 1.4 | 1.31 | 1.27 | 1.47 |
Goodwill | - | 276.2 | 277.5 | 277.5 | 169.57 | 153.13 |
Other Intangible Assets | 386.7 | 117.3 | 133.8 | 150.61 | 119.43 | 104.35 |
Long-Term Deferred Tax Assets | 4.6 | 1.6 | 1.4 | 2.3 | 0.46 | - |
Other Long-Term Assets | 7.6 | 7.6 | 6.6 | 3.46 | 9.39 | 13.11 |
Total Assets | 1,153 | 1,214 | 1,003 | 1,022 | 729.47 | 783.08 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 241.5 | 248 | 175.3 | 152 | 68.94 | 78.12 |
Accrued Expenses | - | 60.3 | 55.5 | 56.79 | 38.64 | 36.38 |
Short-Term Debt | - | - | - | - | - | 0.04 |
Current Portion of Long-Term Debt | 21.4 | 76.3 | 1.6 | 1.63 | 1.67 | 1.63 |
Current Portion of Leases | - | 10 | 8.1 | 7.15 | 5.88 | 4.74 |
Current Income Taxes Payable | - | 0.4 | 0.5 | 0.57 | 0.24 | 0.78 |
Other Current Liabilities | 76.2 | 5 | 8.7 | 5.6 | 3.94 | 2.41 |
Total Current Liabilities | 339.1 | 400 | 249.7 | 223.72 | 119.31 | 124.09 |
Long-Term Debt | 333.1 | 262.9 | 209.9 | 204.35 | 199.75 | 195.38 |
Long-Term Leases | - | 67.4 | 27.7 | 30.68 | 27.59 | 26.06 |
Pension & Post-Retirement Benefits | 0.3 | 0.4 | 2.4 | 4.5 | 5.69 | 5.95 |
Long-Term Deferred Tax Liabilities | 4 | 4.4 | 3.6 | 6.32 | 7.89 | 13.55 |
Other Long-Term Liabilities | - | - | - | - | 14.62 | 2.65 |
Total Liabilities | 676.5 | 735.1 | 493.3 | 469.56 | 374.84 | 367.66 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 759.5 | 0.4 | 0.4 | 0.4 | 0.36 | 0.36 |
Additional Paid-In Capital | - | 755.5 | 754.9 | 733.03 | 570.7 | 566.54 |
Retained Earnings | - | -358.2 | -324.3 | -279.26 | -285.43 | -207.78 |
Comprehensive Income & Other | -301.2 | 61.5 | 53 | 68.03 | 69 | 56.3 |
Total Common Equity | 458.3 | 459.2 | 484 | 522.19 | 354.63 | 415.41 |
Minority Interest | 18.2 | 20 | 26 | 29.84 | - | - |
Shareholders' Equity | 476.5 | 479.2 | 510 | 552.03 | 354.63 | 415.41 |
Total Liabilities & Equity | 1,153 | 1,214 | 1,003 | 1,022 | 729.47 | 783.08 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 354.5 | 416.6 | 247.3 | 243.79 | 234.89 | 227.84 |
Net Cash (Debt) | -222.1 | -213.1 | -69.7 | -39.63 | -54.79 | 55.99 |
Net Cash Growth | - | - | - | - | - | -37.80% |
Net Cash Per Share | - | -10.60 | -3.48 | -2.06 | -3.05 | 3.13 |
Filing Date Shares Outstanding | - | 20.11 | 20.34 | 20.2 | 18.2 | 18.1 |
Total Common Shares Outstanding | - | 20.11 | 20.34 | 20.2 | 18.2 | 18.1 |
Working Capital | 208.8 | 219.4 | 250.3 | 275.79 | 224.61 | 308.68 |
Book Value Per Share | - | 22.83 | 23.79 | 25.85 | 19.49 | 22.96 |
Tangible Book Value | 71.6 | 65.7 | 72.7 | 94.09 | 65.63 | 157.94 |
Tangible Book Value Per Share | - | 3.27 | 3.57 | 4.66 | 3.61 | 8.73 |
Land | - | 10 | 6.6 | 5.3 | 6.43 | 37.88 |
Machinery | - | 59.2 | 53.4 | 49.74 | 43.53 | 35.25 |
Construction In Progress | - | 65.8 | 1 | 0.73 | 3.82 | 5.92 |